Fundraising FoxBiotech Startups
11,136 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
Soteria Biotherapeutics develops protein-based biotherapeutics and small molecules using its LITE Switch technology platform for drug discovery and development across oncology, immune-oncology, and inflammatory disease indications.
0 investors
Sound Pharmaceuticals (SPI) is a Seattle-based biotech developing drug therapeutics, including its lead candidate SPI-1005, to prevent and treat sensorineural hearing loss, tinnitus, and Meniere's disease. Its treatments target inner ear disorders for which there are currently no FDA-approved drugs.
0 investors
0 investors
Southeastern Fiber Corporation develops fiber-based materials made from repurposed banana plant byproduct, with applications in nonwoven materials, nanotechnology, and horticulture. Its brands include Banana Bloom, a dry organic soil amendment surfactant for home gardeners, greenhouses, and nurseries, and BananaTurf, a banana-fiber root zone technology for golf courses and sports fields.
0 investors
0 investors
0 investors
0 investors
Spectral Platforms develops imaging and sensing technologies based on optical and materials science innovations. The company was founded by Ravi Verma, a materials scientist with expertise in optics and MEMS, and is supported by a board of distinguished scientists and industry leaders.
0 investors
0 investors
0 investors
0 investors
Spheryx develops Total Holographic Characterization technology for analyzing suspensions at the sub-visible particle level, including detecting protein aggregates and particles in biopharmaceuticals. Its analytical tools serve product development, manufacturing, and quality assurance across industries such as pharmaceuticals, cosmetics, chemicals, industrial fluids, and petroleum products.
0 investors
0 investors
0 investors
0 investors
Spinnaker Biosciences develops porous silicon, porous silicon oxide, and silicon/polymer composite materials engineered as controlled-release drug delivery vehicles. Its biocompatible, biodegradable particles provide protected storage and sustained release of therapeutic payloads, with surface chemistry that supports targeting agents such as peptides and antibodies.
0 investors
Spinogenix is a biopharmaceutical company developing therapies to restore synaptic function, with a pipeline aimed at neurological and neurodegenerative conditions.
0 investors
Split Biosciences (Parse Biosciences) develops Evercode, an instrument-free combinatorial (split-pool) barcoding technology for scalable single cell sequencing. It sells end-to-end kits and analysis software for researchers and laboratories performing single cell RNA sequencing and immune profiling.
0 investors
Spoke Sciences develops patented formulation technology that makes lipophilic plant-derived functional ingredients (such as CoQ10, resveratrol, and fat-soluble vitamins) water-soluble and taste-neutral for use in beverages and topical/personal care products. It licenses these proprietary ingredients to consumer products manufacturers, addressing potency, bioavailability, stability, taste, and skin-feel challenges.
0 investors
0 investors
0 investors